bathocuproine disulfonate has been researched along with sq-23377 in 1 studies
Studies (bathocuproine disulfonate) | Trials (bathocuproine disulfonate) | Recent Studies (post-2010) (bathocuproine disulfonate) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
---|---|---|---|---|---|
103 | 0 | 25 | 4,385 | 10 | 493 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hardy, K; Hunt, NH | 1 |
1 other study(ies) available for bathocuproine disulfonate and sq-23377
Article | Year |
---|---|
Effects of a redox-active agent on lymphocyte activation and early gene expression patterns.
Topics: Antioxidants; Cell Proliferation; Chelating Agents; Copper; Extracellular Signal-Regulated MAP Kinases; Gene Expression Profiling; Gene Expression Regulation; Humans; Interleukin-2; Ionomycin; Lymphocyte Activation; NF-kappaB-Inducing Kinase; Phenanthrolines; Phosphorylation; Proline; Protein Serine-Threonine Kinases; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thiocarbamates; Transcription Factor AP-1 | 2004 |